Showing results (81-90 of 124) with videos related to

Sort By:
Pageof 13
International Journal of Cardiology|March 15, 2024
Renal impairment and outcome in Takotsubo syndrome: Insights from a national multicentric cohortRavi Vazirani, Manuel Almendro Delia, Emilia Blanco-Ponce, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|March 30, 2019
Renin-Angiotensin System Blockade and Risk of Heart Failure After Myocardial Infarction Based on Left Ventricular Ejection Fraction: A Retrospective Cohort StudyMaría Cespón-Fernández, Sergio Raposeiras-Roubín, Emad Abu-Assi, et al.
Revista Espanola De Cardiologia (English Ed.)|April 25, 2026
Beta-blockers after invasively managed STEMI vs NSTEMI without reduced ejection fraction: a prespecified analysis from the REBOOT trialSergio Raposeiras-Roubín, Manuel Anguita, Roberto Latini, et al.
Journal of Geriatric Cardiology : JGC|April 23, 2016
Impact of concomitant use of proton pump inhibitors and clopidogrel or ticagrelor on clinical outcomes in patients with acute coronary syndromeYan Yan, Xiao Wang, Jing-Yao Fan, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 1, 2025
Effect of beta blocker withholding or withdrawal after myocardial infarction without reduced ejection fraction on ischaemic events: a post hoc analysis from the REBOOT trialXavier Rossello, Pedro L Sánchez, Ruth Owen, et al.
Revista Espanola De Cardiologia (English Ed.)|February 15, 2021
Atrial fibrillation in patients with COVID-19. Usefulness of the CHA2DS2-VASc score: an analysis of the international HOPE COVID-19 registryAitor Uribarri, Iván J Núñez-Gil, Álvaro Aparisi, et al.
European Heart Journal|August 30, 2025
Beta-blockers after myocardial infarction: effects according to sex in the REBOOT trialXavier Rossello, Alberto Dominguez-Rodriguez, Roberto Latini, et al.
Revista Espanola De Cardiologia|March 8, 2021
[Atrial fibrillation in patients with COVID-19. Usefulness of the CHA2DS2-VASc score: an analysis of the international HOPE COVID-19 registry]Aitor Uribarri, Iván J Núñez-Gil, Álvaro Aparisi, et al.
Revista Portuguesa De Cardiologia : Orgao Oficial Da Sociedade Portuguesa De Cardiologia = Portuguese Journal of Cardiology : an Official Journal of the Portuguese Society of Cardiology|January 12, 2023
Long-term prognostic impact of beta-blockers in patients with Takotsubo syndrome: Results from the RETAKO RegistrySergio Raposeiras-Roubín, Iván J Núñez-Gil, Karim Jamhour, et al.
Zhonghua Yi Xue Za Zhi|September 27, 2016
[Impact of concomitant use of P2Y12 inhibitors and proton pump inhibitors on ischemia events in patients with acute coronary syndrome in real world]S T Feng, Y Yan, J Y Fan, et al.
Pageof 13